Alispahic, I.A.; Eklöf, J.; Sivapalan, P.; Jordan, A.R.; Harboe, Z.B.; Biering-Sørensen, T.; Leth-Møller, K.B.; Linneberg, A.; Jensen, J.-U.S.
Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care. Biomedicines 2026, 14, 1197.
https://doi.org/10.3390/biomedicines14061197
AMA Style
Alispahic IA, Eklöf J, Sivapalan P, Jordan AR, Harboe ZB, Biering-Sørensen T, Leth-Møller KB, Linneberg A, Jensen J-US.
Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care. Biomedicines. 2026; 14(6):1197.
https://doi.org/10.3390/biomedicines14061197
Chicago/Turabian Style
Alispahic, Imane Achir, Josefin Eklöf, Pradeesh Sivapalan, Alexander Ryder Jordan, Zitta Barrella Harboe, Tor Biering-Sørensen, Katja Biering Leth-Møller, Allan Linneberg, and Jens-Ulrik Stæhr Jensen.
2026. "Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care" Biomedicines 14, no. 6: 1197.
https://doi.org/10.3390/biomedicines14061197
APA Style
Alispahic, I. A., Eklöf, J., Sivapalan, P., Jordan, A. R., Harboe, Z. B., Biering-Sørensen, T., Leth-Møller, K. B., Linneberg, A., & Jensen, J.-U. S.
(2026). Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin and Amoxicillin in Primary and Secondary Care. Biomedicines, 14(6), 1197.
https://doi.org/10.3390/biomedicines14061197
